We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
iRobot Corporation (IRBT) - free report >>
Edgewell Personal Care Company (EPC) - free report >>
Bassett Furniture Industries, Incorporated (BSET) - free report >>
Image: Bigstock
New Strong Sell Stocks for January 24th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
iRobot Corporation (IRBT - Free Report) designs, builds, and sells robots for the consumer market worldwide. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 30 days.
Edgewell Personal Care Company (EPC - Free Report) manufactures and markets personal care products. The Zacks Consensus Estimate for its current year earnings has declined 0.2% over the last 30 days.
Bassett Furniture Industries, Incorporated (BSET - Free Report) is a leading manufacturer and marketer of high quality, mid-priced home furnishings. It has seen the Zacks Consensus Estimate for its current year earnings being revised 3.6% downward over the last 30 days.
Rent-A-Center, Inc. operates company owned rent-to-own stores which offer high-quality, durable goods. The Zacks Consensus Estimate revision for its current year earnings was a negative of 62.5% over the last 30 days.
Valeant Pharmaceuticals International, Inc. develops, manufactures and markets a broad range of pharmaceutical products. The Zacks Consensus Estimate for its current year earnings has moved 0.5% lower over the last 30 days.
View the entire Zacks Rank #5 List.